Synthesis of pyranopyrazolo N-glycoside and pyrazolopyranopyrimidine C-glycoside derivatives as promising antitumor and antimicrobial agents

Open access


As a part of systematic investigation of the synthesis and biological activities of pyrazole analogues linked to various heterocyclic systems, a new series of pyrazolo-N-glycoside derivatives, pyrazolopyranopyrimidine and C-glycoside of pyrazolopyranotriazolo-pyrimidine derivatives was synthesized through the reaction of the key intermediate 6-amino-3-methyl-4-(substituted-phenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile (3a,b) with different reagents. Structures of the newly synthesized compounds were elucidated by elemental microanalysis and spectroscopic methods. The compounds were subjected to in vitro antitumor evaluation using the MTT assay. N-(β-D-ribofuranosyl)- and N-(β-D-xylofuranosyl)-6{[(1E)-4-chlorophenyl)-methylene] amino}4-(4-florophenyl)-3-methyl-1,4-dihydropyrano[2,3-c]-pyrazole-5-carbonitrile (6a,b) were the most active compounds against three human cancer cell lines. Also, most of the newly synthesized compounds exhibited high activity towards Gram-negative and Gram-positive bacteria. Compound 6a exhibited excellent activity towards bacteria compared to ofloxacine as the reference drug.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. E. De Clercq Antiviral drugs in current clinical use J. Clin. Virol. 30 (2004) 115–133; DOI: 10.1016/j.jcv.2004.02.009.

  • 2. P. J. O’Dwyer S. A. King J. Plowman C. K. Grieshaber D. F. Hoth and B. Leyland-Jones Pyrazole: preclinical reassessment Invest. New Drug 6 (1988) 305–310.

  • 3. A. Bekhit and T. Abdel-Aziem Design synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents Bioorg. Med. Chem. 12 (2004) 1935–1945; DOI: 10.1016/j.bmc.2004.01.037.

  • 4. K. L. Kees J. J. Fitzgerald K. E. Steiner J. F. Mattes B. Mihan and T. Tosi New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones J. Med. Chem. 39 (1996) 3920–3928.

  • 5. A. Geronikaki E. Babaev J. Dearden W. Dehaen D. Filimonov I. Galaeva V. Krajneva A. Lagunin F. macaev G. Molodavkin V. Poroikov S. Pogrebnoi V. Saloutin A. Stepanchikova E. Stingaci N. Tkach L. Vlad and T. Voroninaf Design synthesis computational and biological evaluation of new anxyiolytics Bioorg. Med. Chem. 12 (2004) 6559–6568; DOI: 10.1016/j.bmc.2004.09.016.

  • 6. D. Sil R. Kumar A. Sharon P. R. Malik and V. Ram Stereoselective alkenylation of a 13-disubstituted pyrazol-5-one through ring transformation of 2H-pyran-2-ones Tetrahedron Lett. 46 (2005) 3807–3809; DOI: 10.1016/j.tetlet.2005.03.207.

  • 7. J. S. Larsen M. A. Zahran E. B. Pedersen and C. Nielsen Synthesis of triazenopyrazole derivatives as potential inhibitors of HIV-1 Monatsh. Chem. 130 (1999) 1167–1173.

  • 8. A. Arrieta J. R. Carrillo F. P. Cossl E. Ortiz M. J. Gomez-Escalonilla A. de la Hoz F. Langa and A. Moreno Efficient tautomerization hydrazone-azomethine imine under microwave irradiation. Synthesis of [43′] and [53′]bipyrazoles Tetrahedron 54 (1998) 13167–13180; DOI: 10.1016/S0040-4020(98)00798-4.

  • 9. G. M. Nitulescu C. Draghici and O. T. Olaru New potential antitumor pyrazole derivatives: Synthesis and cytotoxic evaluation Int. J. Mol. Sci. 14 (2013) 21805–21818; DOI: 10.3390/ijms141121805.

  • 10. J. L. Wang D. Liu Z. J. Zhang S. Shan X. Han S. M. Srinivasula C. M. Croce E. S. Alnemri and Z. Huang Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells Proc. Natl. Acad. Sci. USA 97 (2000) 7124–7129.

  • 11. E. S. El-Tamany F. A. El-Shahed and B. H. Mohamed Synthesis and biological activity of some pyrazole derivatives J. Serb. Chem. Soc. 64 (1999) 9–18.

  • 12. M. E. A. Zaki H. S. Soliman O. A. Hiekal and A. E. Rashad Pyrazolopyranopyrimidines as a class of anti-inflammatory agents Z. Naturforsch. C. 61 (2006) 1–5.

  • 13. F. M. Abdelrazek P. Metz N. H. Metwally and S. F. El-Mahrouky Synthesis and molluscicidal activity of new cinnoline and pyrano[23-c]pyrazole derivatives Arch. Pharm. 339 (2006) 456–460.

  • 14. F. M. Abdelrazek P. Metz O. Kataeva A. Jager and S. F. EI-Mahrouky Synthesis and molluscicidal activity of new chromene and pyrano[23-c]pyrazole derivatives Arch. Pharm. 340 (2007) 543–548.

  • 15. N. Foloppe L. M. Fisher R. Howes A. Potter A. G. S. Robertson and A. E. Surgenor. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening Bioorg. Med. Chem. 14 (2006) 4792–4802; DOI: 10.1016/j.bmc.2006.03.021.

  • 16. S. A. El-Assiery G. H. Sayed and A. Fouda Synthesis of some new annulated pyrazolo-pyrido (or pyrano) pyrimidine pyrazolopyridine and pyranopyrazole derivatives Acta Pharm. 54 (2004) 143–150.

  • 17. C. M. Ashraf S. S. Ali and A. Hussain Organic reaction in aqueous solution Part-VIII: Effect of Sonication on the reaction of thiosemicarbazide with ethyl acetoacetate J. Chem. Soc. Pak. 20 (1998) 145–149.

  • 18. M. M. H. Bhuiyan M. I. Hossain M. A. Alam and M. M. Mahmud Microwave assisted Knoevenagel condensation: synthesis and antimicrobial activites of some arylidene-malononitriles Chem. J. 2 (2012) 31–37.

  • 19. S. R. Jain and A. Kar The antibacterial activity of some essential oils and their combinations. Planta Med. 20 (1971) 118–123; DOI: 10.1055/s-0028-1099675.

  • 20. H. Ericsson and J. C. Sherris Antibiotic sensitivity testing. Report of an international collaborative study Acta Pathol. Microbiol. Scand. Sect. B 217 (1971) 1–90.

  • 21. P. Skehan R. Storeng D. Scudiero A. Monks J. McMahon D. Vistica J. T. Warren H. Bokesch S. Kenny and M. R. Boyd New colorimetric cytotoxicity assay for anticancer drug screening J. Natl. Cancer Inst. 82 (1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.

  • 22. A. Monks D. Scudiero P. Skehan R. Shoemaker K. Paul D. Vistica C. Hose J. Langley P. Cronise A. Vaigro-Wolff M. Gray-Goodrich H. Campbell J. Mayo and J. M. Boyd Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines J. Natl. Cancer Inst. 83 (1991) 757–776; DOI: 10.1093/jnci/83.11.757.

  • 23. A. B. A. El-Gazzar H. N. Hafez and G. A. M. Nawwar New acyclic nucleoside analogues as potential analgesic anti-inflammatory anti-oxidant and anti-microbial derived from pyrimido[45-b]quinolines Eur. J. Med. Chem. 44 (2009) 1427–1436; DOI: 10.1016/j.-ejmech.2008.09.030.

Journal information
Impact Factor

IMPACT FACTOR 2018: 1.405
5-year IMPACT FACTOR: 1.701

CiteScore 2018: 1.47

SCImago Journal Rank (SJR) 2018: 0.314
Source Normalized Impact per Paper (SNIP) 2018: 0.637

Cited By
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 394 232 15
PDF Downloads 178 114 9